2021 Environmental, Social and Governance Report

Year: 2021
Published: 2022-05-26
Status: Processed

Extracted ESG KPIs

KPIs are organized by ESG aspects.

The types of emissions and respective emissions data.

Indicator Unit 2019 2020 2021 2022 2023 2023-2025 2024 2025 Report Pages
Acetone recovered per year from solvent recovery system (Fuzhou Fuxing) tonnes/year 300 197
Ammonia nitrogen tonne 19.2 13 14.9 234
Ammonia nitrogen (APIs) tonne 12.7 184
Ammonia nitrogen (Drug Preparations) tonne 2.2 184
Ammonia nitrogen (Total) tonne 14.9 184
Amount of chemical oxygen demand (CODₓ) emission per RMB10000 of output value Achieved To decrease by 2.2% compared with the previous year To decrease by 2.2% compared with the previous year 177
Amount of sulphur dioxide (SO₂) emission per RMB10000 of output value Achieved To decrease by 2.2% compared with the previous year To decrease by 2.2% compared with the previous year 177
Chemical Oxygen Demand (APIs) tonne 250.6 184
Chemical Oxygen Demand (CODc) tonne 343.2 338.5 269.5 234
Chemical Oxygen Demand (Drug Preparations) tonne 18.9 184
Chemical Oxygen Demand (Total) tonne 269.5 184
Decrease amount of emission per RMB10000 of output value as compared with 2020 % 6 11 17 22 26 178
Emissions of industrial wastewater (APIs) tonne 3542825.2 184
Emissions of industrial wastewater (Drug Preparations) tonne 679858.3 184
Emissions of industrial wastewater (Total) tonne 4222683.5 184
Nitrogen oxides (NOx) tonne 141.1 86.2 135.7 234
Nitrogen oxides emissions - APIs tonne 126.4 179
Nitrogen oxides emissions - Drug Preparations tonne 9.3 179
Nitrogen oxides emissions - Total tonne 135.7 179
Particulate matter tonne Not disclosed Not disclosed 22.9 234
Particulate matter emissions - APIs tonne 21.9 179
Particulate matter emissions - Drug Preparations tonne 1 179
Particulate matter emissions - Total tonne 22.9 179
Reduction in boiler nitrogen oxides emission value after low-nitrogen reform (Pharmaceutical Factory) mg/m3 from 150 mg/m3 to 50 mg/m3 202
Reduction in nitrogen oxides emissions concentration after low-nitrogen renovation of biomass boilers (Sichuan Guangda) mg/m3 98 180
Sulphur dioxide (SO2) tonne 76.3 47.8 45.4 234
Sulphur dioxide emissions - APIs tonne 44.7 179
Sulphur dioxide emissions - Drug Preparations tonne 0.7 179
Sulphur dioxide emissions - Total tonne 45.4 179
Volatile organic compounds (VOCs) tonne Not disclosed Not disclosed 46.4 234
Volatile organic compounds (VOCs) emissions - APIs tonne 45.9 179
Volatile organic compounds (VOCs) emissions - Drug Preparations tonne 0.5 179
Volatile organic compounds (VOCs) emissions - Total tonne 46.4 179

Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2019 2020 2021 Report Pages
Decrease in major greenhouse gas emissions compared with 2020 % -6.71 14
Direct greenhouse gas emissions (Scope 1) CO2 equivalent (in tonnes) 183982 30427.8 193239.7 234
Direct greenhouse gas emissions (Scope 1, APIs) CO2 equivalent (in tonnes) 191694.8 195
Direct greenhouse gas emissions (Scope 1, Drug preparations) CO2 equivalent (in tonnes) 1544.9 195
Direct greenhouse gas emissions (Scope 1, Total) CO2 equivalent (in tonnes) 193239.7 195
Indirect greenhouse gas emissions (Scope 2) CO2 equivalent (in tonnes) 407325.5 543952.5 342591.8 234
Indirect greenhouse gas emissions (Scope 2, APIs) CO2 equivalent (in tonnes) 264838.1 195
Indirect greenhouse gas emissions (Scope 2, Drug preparations) CO2 equivalent (in tonnes) 77753.7 195
Indirect greenhouse gas emissions (Scope 2, Total) CO2 equivalent (in tonnes) 342591.8 195
Intensity of greenhouse gas emissions CO2 equivalent (in tonnes)/RMB10000 0.6 0.5 0.4 234
Intensity of greenhouse gas emissions (APIs) CO2 equivalent (in tonnes)/RMB10000 of output value 1.3 195
Intensity of greenhouse gas emissions (Drug preparations) CO2 equivalent (in tonnes)/RMB10000 of output value 0.1 195
Intensity of greenhouse gas emissions (Total) CO2 equivalent (in tonnes)/RMB10000 of output value 0.4 195
Purchased electricity (Total) kWh 398439861.9 195
Total greenhouse gas emissions CO2 equivalent (in tonnes) 591307.5 574380.3 535831.5 234
Total greenhouse gas emissions (APIs) CO2 equivalent (in tonnes) 456532.9 195
Total greenhouse gas emissions (Drug preparations) CO2 equivalent (in tonnes) 79298.6 195
Total greenhouse gas emissions (Total) CO2 equivalent (in tonnes) 535831.5 195
Total major greenhouse gas emissions (scope 1 and 2) tonnes CO2e 535831.5 14

Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2019 2020 2021 Report Pages
Fuzhou Fuxing - annual output of fungi residues reduced tonnes 3200 188
Fuzhou Fuxing - percentage reduction of annual output of fungi residues 60% 188
Hazardous waste intensity kg/RMB10000 2.8 2.6 2.5 235
Livzon Hecheng - annual output of hazardous waste reduced tonnes 12 188
Medical waste (HW02) and waste medicines (HW03) tonne 1564.5 1826.9 1789.2 235
Medical waste (HW02) and waste medicines (HW03), APIs division tonne 1712.8 187
Medical waste (HW02) and waste medicines (HW03), Drug Preparations division tonne 76.4 187
Medical waste (HW02) and waste medicines (HW03), Total tonne 1789.2 187
Ningxia Pharma - annual output of waste activated carbon reduced tonnes 160 188
Other hazardous waste tonne 1018.5 1153.5 1448.3 235
Other hazardous waste (APIs division) tonne 1326.2 187
Other hazardous waste (Drug Preparations division) tonne 122.1 187
Other hazardous waste (Total) tonne 1448.3 187
Reduction in hazardous waste generation by slag mineralization technology (Fuzhou Fuxing) tonnes/year 1000 197
Total hazardous waste tonne 2583 2980.4 3237.5 235
Total hazardous waste (APIs division) tonne 3039 187
Total hazardous waste (Drug Preparations division) tonne 198.5 187
Total hazardous waste (Total) tonne 3237.5 187

Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2019 2020 2021 2022 2023-2025 Report Pages
Amount of non-hazardous waste disposal per RMB10000 of output value To decrease by 0.8% compared with 2020 To decrease by 0.8% compared with the previous year To decrease by 0.5% compared with the previous year 177
Non-hazardous waste (non-recyclable) tonne 99881.5 55990.2 116301.8 235
Non-hazardous waste (non-recyclable, APIs division) tonne 105556.7 187
Non-hazardous waste (non-recyclable, Drug Preparations division) tonne 10745.1 187
Non-hazardous waste (non-recyclable, Total) tonne 116301.8 187
Non-hazardous waste (recyclable) tonne Not disclosed Not disclosed 1853 235
Non-hazardous waste (recyclable, Drug Preparations division) tonne 1853 187
Non-hazardous waste (recyclable, Total) tonne 1853 187
Non-hazardous waste intensity kg/RMB10000 106.4 48.3 92.2 235
Total non-hazardous waste tonne 99881.5 55990.2 118154.8 235
Total non-hazardous waste (APIs division) tonne 105556.7 187
Total non-hazardous waste (Drug Preparations division) tonne 12598.1 187
Total non-hazardous waste (Total) tonne 118154.8 187

Description of emissions target(s) set and steps taken to achieve them.

Indicator Unit 2021 Report Pages
Carbon emission reduced per year by Ningxia Pharma through boiler renovation tonnes 31000–41000 196

Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.

Indicator Unit 2021 2022 2023-2025 Report Pages
Alcohol recovered per year from solvent recovery system (Fuzhou Fuxing) tonnes/year 8000 197
Alcohol recovery rate from solvent recovery system (Fuzhou Fuxing) 97% or more 197
Amount of hazardous waste disposal per RMB10000 of output value To decrease by 0.5% compared with 2020 To decrease by 0.5% compared with the previous year To decrease by 0.5% compared with the previous year 177
Fuzhou Fuxing - annual disposal expenses saved RMB/year 5400000 188
Guitian Fuxing - upgrade and renovation of sludge press system RMB'000 60 188
Input for centralized treatment of waste gas (Ningxia Pharma) RMB 10000 60 180
Input for dust collection and treatment of coal conveyor corridors (Ningxia Pharma) RMB 10000 20 180
Input for installation of online monitoring equipment to RTO (Ningxia Pharma) RMB 10000 40 180
Input for installation of waste gas collection and treatment facilities in the storage of hazardous waste (Ningxia Pharma) RMB 10000 5 180
Input for low-nitrogen renovation of biomass boilers (Sichuan Guangda) RMB 10000 114.1 180
Input for treatment of waste gas generated from the doramectin acidification tank of workshop 101 (Ningxia Pharma) RMB 10000 2 180
Livzon Hecheng - annual disposal expenses saved RMB/year 48000 188
Shanghai Livzon - hazardous waste temporary storage floor improvement RMB'000 1.3 188
Treatment cost saved by slag mineralization technology (Fuzhou Fuxing) RMB/year 1500000 197

Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2019 2020 2021 2022 2023-2025 Report Pages
Alcohol based liquid fuel consumption (direct renewable energy) tonne 18.5 20.2 236
Amount of electricity consumption per RMB10000 of output value To decrease by 3% compared with 2020 To decrease by 3% compared with the previous year To decrease by 3% compared with the previous year 177
Biomass fuel consumption (Drug preparations) tonne 14.4 195
Biomass fuel consumption (Total) tonne 14.4 195
Biomass fuel consumption (direct renewable energy) tonne 6466 14.4 236
Coal consumption (APIs) tonne 86291 195
Coal consumption (Total) tonne 86291 195
Coal consumption (direct, non-renewable fuel) tonne 72714.2 4336.5 86291 236
Diesel consumption (APIs) liter 243286.5 195
Diesel consumption (Drug preparations) liter 84779.1 195
Diesel consumption (Total) liter 328065.6 195
Diesel consumption (direct, non-renewable fuel) litre 362836.3 356192.6 328065.6 236
Direct energy consumption MWh Not disclosed Not disclosed 572945.5 236
Electricity generated by biogas from slag mineralization technology (Fuzhou Fuxing) kWh/year 250000 197
Fuzhou Fuxing - Photovoltaic power generation - Electricity generated kWh 63000 203
Gasoline consumption (APIs) liter 136178.1 195
Gasoline consumption (Drug preparations) liter 148487.5 195
Gasoline consumption (Total) liter 284665.6 195
Gasoline consumption (direct, non-renewable fuel) litre 365628.3 278223.1 284665.6 236
Indirect energy consumption MWh Not disclosed Not disclosed 687587.4 236
Intensity of purchased electricity kWh/RMB10000 398.6 345.6 311.1 236
Intensity of total energy consumption MWh/RMB10000 Not disclosed Not disclosed 1 236
Intensity of total energy consumption (APIs) MWh/RMB10000 of output value 3.2 195
Intensity of total energy consumption (Drug preparations) MWh/RMB10000 of output value 0.2 195
Intensity of total energy consumption (Total) MWh/RMB10000 of output value 1 195
Liquefied petroleum gas consumption (APIs) tonne 4.3 195
Liquefied petroleum gas consumption (Drug preparations) tonne 3.6 195
Liquefied petroleum gas consumption (Total) tonne 7.9 195
Liquefied petroleum gas consumption (direct, non-renewable fuel) tonne Not disclosed Not disclosed 7.9 236
Natural gas consumption (APIs) 10000 cubic meters 554.3 195
Natural gas consumption (Drug preparations) 10000 cubic meters 44.3 195
Natural gas consumption (Total) 10000 cubic meters 598.6 195
Natural gas consumption (direct, non-renewable fuel) 10000 cubic meters 1111.5 917.9 598.6 236
Pharmaceutical Factory - Photovoltaic power generation - Electricity generated kWh 630000 203
Purchased electricity (APIs) kWh 316679138 195
Purchased electricity (Drug preparations) kWh 81760723.9 195
Purchased electricity (indirect energy) kWh 374098694.8 400450102.9 398439861.9 236
Purchased steam (APIs) tonne 275845.4 195
Purchased steam (Drug preparations) tonne 100295.1 195
Purchased steam (Total) tonne 376140.5 195
Purchased steam (indirect energy) tonne 284016.2 666196.9 376140.5 236
Solar power (self-use) (APIs) kWh 62888 195
Solar power (self-use) (Drug preparations) kWh 629392 195
Solar power (self-use) (Total) kWh 692280 195
Solar power (self-use, direct renewable energy) kWh Not disclosed Not disclosed 692280 236
Total energy consumption MWh Not disclosed Not disclosed 1260532.9 236

Water consumption in total and intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2019 2020 2021 2022 2023-2025 Report Pages
Amount of water consumption per RMB10000 of output value Achieved To decrease by 3% compared with the previous year To decrease by 3% compared with the previous year 177
Fresh water consumption tonne 6385615.3 6264353.1 6096512.8 237
Fresh water consumption (APIs division) tonne 4539298 191
Fresh water consumption (Drug Preparations division) tonne 1557214.8 191
Fresh water consumption (Total) tonne 6096512.8 191
Industrial wastewater tonne 4368313.4 4285515 4222683.5 234
Intensity of water consumption (fresh water) tonne/RMB10000 6.8 5.4 4.8 237
Recycled water volume tonne Not disclosed Not disclosed 2400 237
Recycled water volume (Drug Preparations division) tonne 2400 191
Recycled water volume (Total) tonne 2400 191

Description of energy use efficiency target(s) set and steps taken to achieve them.

Indicator Unit 2021 Report Pages
Coal consumption cut by Ningxia Pharma through increased external steam supply tonnes 28000 196
Coal saved annually by Ningxia Pharma through phenylalanine concentration system renovation tonnes 9300 196
Coal saved per year by Ningxia Pharma through boiler renovation tonnes 15000–20000 196
Electricity expenses saved annually by Shanghai Livzon through solid preparation workshop transformation RMB 50000 199
Electricity expenses saved annually by Xinbeijiang Pharma through MVR equipment repair and maintenance RMB 240000 199
Electricity expenses saved annually by Xinbeijiang Pharma through cooling tower technological renovation RMB 48000 199
Electricity saved annually by Gutian Fuxing through air compressor and chiller unit replacement kilowatt-hours 400000 196
Electricity saved annually by Gutian Fuxing through air compressor replacement kilowatt-hours 6000000 196
Electricity saved monthly by Gutian Fuxing through air compressor replacement kilowatt-hours 500000 196
Electricity saved per year by Ningxia Pharma through equipment replacement kilowatt-hours 2300000 196
Electricity savings from energy-efficient central screw air conditioning units (Livzon Diagnostics) % not less than 35 202
Electricity savings from maintenance and optimization of key energy-consuming equipment (Livzon Diagnostics) % not less than 3 202
Electricity savings from refurbished photovoltaic inverter cabinets and roof-mounted photovoltaic modules (Pharmaceutical Factory) kWh per year 600000 202
Electricity savings from replacing incandescent lamps with LED lamps (Pharmaceutical Factory) % not less than 10 202
Energy saved by renovating high-energy-consuming pumps (Fuzhou Fuxing) kWh/year 800000 197
Energy saved by replacing with high-efficiency water motor pumps (Fuzhou Fuxing) kWh/year 800000 197
Energy saved by replacing with new air pressure system (Fuzhou Fuxing) kWh/year 1800000 197
Investment to replace milbemycin reaction tanks (Fuzhou Fuxing) RMB 65000 160
Investment to upgrade and improve production process and equipment (Fuzhou Fuxing) RMB 5120000 160
Investment to upgrade automatic control system (Jiaozuo Hecheng) RMB 1800000 160
Investment to upgrade hazardous chemical product equipment (Livzon Hecheng) RMB 2180000 160
Livzon Hecheng - Equipment replacement - Electricity savings from Roots blowers replacement kWh per year 107000 198
Livzon Hecheng - Equipment replacement - Electricity savings from upgraded chiller units kWh annually 120000 198
Livzon Hecheng - Equipment replacement - Energy savings from replacing traditional units % 30 198
Livzon Hecheng - Technological renovation - Electricity savings from graphene film kWh annually 100000 198
Livzon Hecheng - Technological renovation - Energy savings from graphene film % 5 198
Natural gas expenses saved annually by Xinbeijiang Pharma through air compressor equipment replacement RMB 350000 199
Natural gas expenses saved annually by Xinbeijiang Pharma through boiler equipment replacement RMB 480000 199
Natural gas savings from purchased steam to reduce boiler combustion (Pharmaceutical Factory) cubic meters 1500000 202
Peptide splicing yield increase at Shanghai Livzon through manufacturing process improvement % more than 10 199
Percentage energy saved by renovating high-energy-consuming pumps (Fuzhou Fuxing) 20% 197
Percentage energy saved by replacing 4 high energy-consuming Roots blowers (Fuzhou Fuxing) 30% 197
Percentage energy saved by replacing with high-efficiency water motor pumps (Fuzhou Fuxing) 20% 197
Percentage energy saved by replacing with new air pressure system (Fuzhou Fuxing) more than 20% 197
Sichuan Guangda - Energy management - Energy savings compared to manual control % 30 198
Sichuan Guangda - Manufacturing process improvement - Cost reduction % 60 198
Sichuan Guangda - Manufacturing process improvement - Energy savings % 50 198
Sichuan Guangda - Manufacturing process improvement - Increase production efficiency % 30 198
Steam saved annually by Ningxia Pharma through phenylalanine concentration system renovation tonnes 42000 196
Steam saved in Limin Factory R&D Centre by renovating air-conditioning ventilation system tonnes 180 200
Steam saved in Limin Factory solid preparation and high-volume workshop tonnes 180 200
Steam saved in Limin Factory solid workshop by adjusting air conditioning settings tonnes 500 200

Description of whether there is any issue in sourcing water that is fit for purpose, water efficiency target(s) set and steps taken to achieve them.

Indicator Unit 2021 Report Pages
Estimated annual freshwater saving from collection and reuse of RO wastewater at Jiaozuo Hecheng tonnes 1080 192
Estimated annual freshwater saving from reuse of steam condensate at Jiaozuo Hecheng tonnes 1200 192
Estimated annual underground water saving from cooling tower project for water conservation at Ningxia Pharma 30000 192
Estimated annual wastewater discharge reduction from recycling of MVR condensate water at Ningxia Pharma 60000 192
Estimated annual water cost saving from reuse of wastewater at Limin Factory RMB 140000 192
Estimated annual water saving from renovation of fire protection pipe network at Livzon Hecheng tonnes 500 192
Estimated annual water saving from replacement of water saving taps at Fuzhou Fuxing tonnes 100-200 192
Estimated annual water saving from reuse of wastewater at Limin Factory tonnes 32400 192

Total packaging material used for finished products (in tonnes) and, if applicable, with reference to per unit produced.

Indicator Unit 2019 2020 2021 Report Pages
Intensity of packaging material used kg/RMB10000 3.3 3.1 7.9 237
Other packaging material tonne Not disclosed Not disclosed 6370.8 237
Other packaging material (APIs) tonne 1333.8 206
Other packaging material (Drug preparations) tonne 5037 206
Other packaging material (Total) tonne 6370.8 206
Paper packaging material tonne 3095.7 3628.1 3791.5 237
Paper packaging material (APIs) tonne 605.2 206
Paper packaging material (Drug preparations) tonne 3186.3 206
Paper packaging material (Total) tonne 3791.5 206
Total packaging material used tonne 3095.7 3628.1 10162.3 237

Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.

Indicator Unit 2020 2021 Report Pages
Best ESG Award (International Roadshow Center) Awarded 16
Capitalized R&D investment as percentage of total R&D investment % 10.66 24.79 49
EHS management investment million RMB 106.7 14
Investment in environmental protection million RMB 79.75 14
Investment to carry out HAZOP analysis and optimize process design (Fuzhou Fuxing) RMB 102000 160
Investments in operations and maintenance of environmental protection million RMB 65.378 173
Investments in technical renovations of environmental protection million RMB 14.3724 173
Maintenance of environmental protection facilities million RMB 65.38 14
Number of agreements with natural reserve at state level 1 14
Renovation of environmental protection facilities million RMB 14.37 14

Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.

Indicator Unit 2017 2018 2019 2019-2021 2020 2021 Report Pages
Average percentage of women in executive management (2019-2021) % 25 130
Employee age distribution: aged 30 and below % 37 130
Employee age distribution: aged 31-49 % 57 130
Employee age distribution: aged 50 and above % 6 130
Female directors as percentage of Board % 9 130
Female executive management members as percentage % 25 130
Governance of the Board – TOP 20 Listed Companies in the Great Bay Area (Shenzhen Research Association of Corporate Governance) Awarded 16
Number of Board members 11 130
Number of R&D employees employees 585 721 729 911 936 14, 48
Number of employees - Director level person 201 182 238
Number of employees - General manager level and above person 73 84 238
Number of employees - Manager level person 900 850 238
Number of employees - Other employees person 7193 7464 238
Number of employees aged 30 and below person 3780 3303 3191 238
Number of employees aged 31-49 person 4838 4651 4931 238
Number of employees aged 50 and above person 401 413 458 238
Number of employees by educational attainment - College diploma employees 2393 126
Number of employees by educational attainment - Doctor employees 47 126
Number of employees by educational attainment - Less than college diploma employees 3246 126
Number of employees by educational attainment - Master employees 442 126
Number of employees by educational attainment - Undergraduate employees 2452 126
Number of employees by function - Administrative staff employees 455 126
Number of employees by function - Financial staff employees 172 126
Number of employees by function - Production staff employees 5002 126
Number of employees by function - Sales staff employees 1802 126
Number of employees by function - Technical staff employees 1149 126
Number of employees by gender - Female employees 4088 126
Number of employees by gender - Male employees 4492 126
Number of employees in Hong Kong, Macau and Taiwan of China person 1 4 2 238
Number of employees in Mainland China person 9012 8353 8569 238
Number of employees overseas person 6 10 9 238
Number of ethnic minority employees 408 131
Number of executive management members 8 130
Number of female employees person 4223 3975 4088 238
Number of foreign employees 9 131
Number of male employees person 4796 4392 4492 238
Number of women in management positions at manager level or above 391 131
Percentage of R&D employees 8.42% 9.40% 8.68% 10.89% 10.91% 48
Percentage of R&D investment to total operating income % 6.75 7.76 8.82 9.41 12.63 49
Percentage of female employees % 44 45.5 46.8 47.5 47.7 131
Proportion of female employees in workforce % 47.5 47.7 131
Proportion of women in management positions at manager level or above % 35 131
Total amount paid to employees (wages, bonuses, allowances, compensation, welfare, housing funds, social insurance) million RMB 1382.17 14
Total number of employees employees, person 9019 8367 8580 126, 238
Total number of female employees persons 3061 3494 4223 3975 4088 131
Total wages, bonuses, allowances, compensation, welfare, housing funds and social insurance paid to employees million RMB 1051.79 1382.17 143

Employee turnover rate by gender, age group and geographical region.

Indicator Unit 2019 2020 2021 Report Pages
Employee turnover rate - Age 30 and below % 19.22 21.66 238
Employee turnover rate - Age 31-49 % 12.6 18.44 238
Employee turnover rate - Age 50 and above % 4.12 21.78 238
Employee turnover rate - Female % 15.02 19.08 238
Employee turnover rate - Hong Kong, Macau and Taiwan of China % 25 40 238
Employee turnover rate - Mainland China % 14.79 19.72 238
Employee turnover rate - Male % 14.59 20.73 238
Employee turnover rate - Overseas % 20 37.5 238
Employee voluntary turnover rate % 16.81 14.8 11.11 238
Operating income million RMB 12063.86 14
Total employee turnover rate % 16.81 14.8 19.95 132, 238
Voluntary employee turnover rate % 14.8 11.11 132

Lost days due to work injury.

Indicator Unit 2019 2020 2021 Report Pages
Lost days due to work injury day 547 155 180 239

Description of occupational health and safety measures adopted, and how they are implemented and monitored.

Indicator Unit 2021 Report Pages
Investment in safe production (total) RMB 22860000 160
Investment in safe production and occupational health million RMB 26.95 14
Investment to establish dedicated emergency rescue team (Fuzhou Fuxing) RMB 190000 160
Investment to set up automatic sprinkler fire-fighting and fire detection system (Livzon Hecheng) RMB 1300000 160
Number of emergency drills (Fuzhou Fuxing) drills 6 160
Number of quarterly assessments by emergency team (Fuzhou Fuxing) assessments 3 160
Number of safety trainings conducted by Livzon Hecheng 75 167
Number of transferal safety trainings conducted at Pharmaceutical Factory trainings 191 166

The percentage of employees trained by gender and employee category (e.g. senior management, middle management).

Indicator Unit 2017 2018 2019 2020 2021 Report Pages
Number of departmental trainings organized by Xinbeijiang Pharma 182 167
Number of new employees receiving Level 3 safety trainings at Pharmaceutical Factory employees 363 166
Number of subjects covered in Livzon Hecheng safety trainings 45 167
Number of training sessions for emergency rescue team (Fuzhou Fuxing) sessions 29 160
Number of trainings for external workers by Livzon Hecheng 246 167
Number of weekly safety trainings conducted by Livzon Hecheng 45 167
Percentage of director level employees who took part in training % 1.94 2.12 239
Percentage of female employees who took part in training % 47.88 47.65 239
Percentage of general manager level and above employees who took part in training % 0.35 0.98 239
Percentage of manager level employees who took part in training % 7.03 9.91 239
Percentage of other employees who took part in training % 90.67 86.99 239
Percentage of total employees who took part in training % 99.56 100 239
R&D employees as percentage of total employees % 10.91 14
R&D investment RMB million 575.5 687.24 827.73 989.59 1523.26 49
R&D investment as percentage of operating income % 12.63 14
Total R&D expenditure million RMB 1523.26 14

The average training hours completed per employee by gender and employee category.

Indicator Unit 2019 2020 2021 Report Pages
Average length of safety trainings per employee at Ningxia Pharma hours/year 20 166
Average training hours per director level employee hour 23.9 52.6 239
Average training hours per employee hour 65 42.3 76.2 239
Average training hours per female employee hour 59.4 42.2 76.2 239
Average training hours per general manager level and above employee hour 7.7 16.9 239
Average training hours per male employee hour 70 42.4 76.2 239
Average training hours per manager level employee hour 23.4 56.2 239
Average training hours per other employees hour 45.5 79.7 239
Level 3 safety training hours required for new employees before employment at Ningxia Pharma hours 72 166
Percentage of male employees who took part in training % 52.12 52.35 239
Training passing rate for external workers at Livzon Hecheng 100% 167

Number of suppliers by geographical region.

Indicator Unit 2019 2020 2021 Report Pages
Percentage/number of Central China suppliers %/number 8% 7% 148 240
Percentage/number of Eastern China suppliers %/number 41% 38% 837 240
Percentage/number of Northeastern China suppliers %/number 1% 1% 30 240
Percentage/number of Northern China suppliers %/number 9% 9% 196 240
Percentage/number of Northwestern China suppliers %/number 7% 5% 99 240
Percentage/number of Southern China suppliers %/number 31% 36% 689 240
Percentage/number of Southwestern China suppliers %/number 2% 2% 47 240
Percentage/number of overseas suppliers %/number 1% 1% 9 240
Total number of suppliers 2055 240

Number of products and service related complaints received and how they are dealt with.

Indicator Unit 2019 2020 2021 Report Pages
Customer satisfaction survey - Packaging percent 100% 98.6% 97.9% 93
Customer satisfaction survey - Product efficacy percent 100% 100% 100% 93
Customer satisfaction survey - Product quality percent 100% 100% 100% 93
Ilaprazole Sodium for Injection price after reduction (China, 2021) RMB per unit 71 67
Ilaprazole Sodium for Injection price before reduction (China, 2021) RMB per unit 156 67
Medication queries time 8 8 9 240
Number of customer feedbacks received in written forms 282 93
Number of products included in national medical insurance catalogue 186 14
Number of products included in the Medical Insurance Catalogue (China, end of reporting period) products 186 67
Number of responses in Andrographolide Capsules survey - primary hospitals responses 2 93
Number of responses in Andrographolide Capsules survey - secondary hospitals responses 24 93
Number of responses in Andrographolide Capsules survey - tertiary hospitals responses 29 93
Product-related complaints time 121 137 142 240
Year-on-year increase in R&D expenditure % 53.93 14

Description of practices relating to observing and protecting intellectual property rights.

Indicator Unit 2021 Report Pages
International certification of APIs (internationally certified varieties) products 17 81
International certification of APIs (internationally recognized certificates) certificates 49 81
International certification of APIs (products obtained CEP certificates) products 12 81
International certification of APIs (products passed FDA on-site inspections) products 4 81
International certification of drug preparations (internationally certified varieties) product 1 81
International certification of drug preparations (internationally recognized certificates) certificates 2 81
International registration of APIs (countries/regions) countries/regions 56 81
International registration of APIs (products) products 28 81
International registration of APIs (projects completed) projects 104 81
International registration of drug preparations (countries/regions) countries/regions 194 81
International registration of drug preparations (products) products 12 81
International registration of drug preparations (projects completed) projects 13 81
Price reduction of Ilaprazole Sodium for Injection (China, 2021) percent over 50% 67
Top 100 Chinese Pharmaceutical Innovative Enterprises Awarded 15

Description of quality assurance process and recall procedures.

Indicator Unit 2021 Report Pages
GMP compliance status of API production lines production lines 42 81
GMP compliance status of drug preparation production lines production lines 39 81
ISO quality management system certification (enterprises certified to GB/T 19001-2016/ISO 9001:2015) enterprises 2 81
ISO quality management system certification (enterprises certified to ISO 22000:2018 Food Safety Management System) enterprise 1 81
Number of drugs in class A list of Medical Insurance Catalogue (China, end of reporting period) drugs 90 67
Number of drugs in class B list of Medical Insurance Catalogue (China, end of reporting period) drugs 96 67

Description of consumer data protection and privacy policies, and how they are implemented and monitored.

Indicator Unit 2021 Report Pages
Best Information Disclosure Award (International Roadshow Center) Awarded 16

Number of concluded legal cases regarding corrupt practices brought against the issuer or its employees during the reporting period and the outcomes of the cases.

Indicator Unit 2021 Report Pages
Number of shares purchased under First Phase Ownership Scheme shares 2348960 142

Description of preventive measures and whistle-blowing procedures, and how they are implemented and monitored.

Indicator Unit 2020 2021 Report Pages
Date of appointment of Tian Qiusheng as ESG Committee member 29 July 2021 21
Date of establishment of ESG Committee 30 June 2020 21
Number of ESG Committee meetings held meetings 3 21
Number of drills organized by Xinbeijiang Pharma 161 167

Description of anti-corruption training provided to directors and staff.

Indicator Unit 2021 Report Pages
Number of directors attended anti-corruption training person 8 241
Number of employees attended anti-corruption training person 8580 241
Total number of hours of anti-corruption training provided to directors hour 11.5 241
Total number of hours of anti-corruption training provided to employees hour 35375.9 241

Focus areas of contribution (e.g. education, environmental concerns, labour needs, health, culture, sport).

Indicator Unit 2020 2021 Report Pages
Donation to society million RMB 19.45 14
Excellent Practice Case for Listed Companies from 2020 Annual Report Results Presentation Awarded 15
Humanitarian Award of Zhuhai Red Cross Awarded 15
Number of agreements with remote areas in need of assistance 14 14
Outstanding Contribution Award for Enterprise Management in the 13th Five-Year of the Pharmaceutical Industry Awarded 15
Outstanding Contribution Award of Technology Innovation for Food and Pharmaceutical Devices in Zhuhai Awarded 15
Rank of Social Responsibility of Pharmaceutical Manufacturing Companies – Outstanding Responsible Enterprise of the Year Awarded 15
Reputation List of China Listed Companies – Best Socially Responsible Listed Company Awarded 15
Tax revenue contributed million RMB 1360.74 14
The 11th China Securities Golden Bauhinia Award for Listed Company with Best Investment Value under the 14th Five-Year Plan (Hong Kong Ta Kung Wen Wei Media Group) Awarded 16
The 11th China Securities Golden Bauhinia Award for the Best ESG Practice of Listed Company (Hong Kong Ta Kung Wen Wei Media Group) Awarded 16
The 1st Jinglun Award for China Listed Company with Investor Relation Value: Best Investor Relation Value Award of the Year, Listed Company favored the most by Private Equity of the Year (China Fund News) Awarded 16
Top 100 Enterprises in China Pharmaceutical Industry: 23rd Place place 23 15
Zhuhai Charity Award: Charity Model Awarded 15

Resources contributed (e.g. money or time) to the focus area.

Indicator Unit 2021 Report Pages
Charitable donation to China Primary Health Care Foundation RMB 250000 219
Charitable donation to Chinese Red Cross Foundation (drugs for flood relief in Hunan) million RMB 5 219
Charitable donation to Guiyang City Public Health Treatment Center, the Fourth People’s Hospital of Zunyi City (medical devices) million RMB 1 219
Charitable donation to Ministry of Health of Malaysia (ICU beds) US dollars 245600 219
Charitable donation to Nanjing China Pharmaceutical University Education Development Foundation RMB 150000 219
Charitable donation to Peking University Education Foundation (Development Fund of Medical Education) million RMB 5 219
Charitable donation to Red Cross Society of Zunyi City (testing equipment for COVID-19 pandemic prevention and control) million RMB 1.5 219
Charitable donation to School of Basic Medicine and Clinical Pharmacy of China Pharmaceutical University (Livzon Scholarship) RMB 100000 219
Charitable donation to Union Hospital of Tongji Medical College, Huazhong University of Science and Technology (COVID-19 protective suites) RMB 140000 219
Charitable donation to Zhongshan Medical Foundation of Guangdong Province (first-aid kits) RMB 150000 219
Charitable donation to patients with chronic diseases in financial difficulties in Fenyi County in Jiangxi Province (drugs for chronic diseases) million RMB 1 219
Charitable donation to patients with chronic diseases in financial difficulties in Huangshan District of Huangshan City in Anhui Province (drugs for chronic diseases) million RMB 1 219
Charitable donation to patients with chronic diseases in financial difficulties in Macun District of Jiaozuo City in Henan Province (drugs for chronic diseases) million RMB 1 219
Charitable donation to patients with chronic diseases in financial difficulties in Suining County in Hunan Province (drugs for chronic diseases) million RMB 1 219
Expenditure on charitable donation million RMB 19.45 14
Funds donation (charitable) million RMB 13.5 14
Materials donation (charitable) million RMB 5.95 14
Number of public welfare agreements for chronic disease prevention and treatment 16 14
Number of registered people in need (public welfare) 5000 14
Social contribution per share RMB per share 3.04 14

The types of emissions and respective emissions data.

Standard Indicator Unit 2019 2020 2021
Airborne Particulate Matter (PM) Emissions tonne 22.9
NOₓ Emissions tonne 141.1 86.2 135.7
SOₓ Emissions tonne 76.3 47.8 45.4

Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2019 2020 2021
Direct GHG Emissions (Scope 1) tonnes CO2e 183982 30427.8 193239.7
Indirect Energy Emissions (Scope 2) tonnes CO2e 407325.5 543952.5 342591.8
Total GHG Emissions tonnes CO2e 591307.5 574380.3 535831.5
Total GHG Emissions Intensity (By Revenue) tonnes CO2e/RMB10000 0.6 0.5 0.4

Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2019 2020 2021
Total Hazardous Waste tonne 2583 2980.4 3237.5
Total Hazardous Waste Intensity (By Revenue) kg/RMB10000 2.8 2.6 2.5

Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2019 2020 2021
Non-Hazardous Waste Disposed tonne 99881.5 55990.2 118154.8
Non-Hazardous Waste Recycled tonne None None 1853
Total Non-Hazardous Waste Intensity (By Revenue) kg/RMB10000 106.4 48.3 92.2

Description of emissions target(s) set and steps taken to achieve them.

Standard Indicator Unit 2021
CO2 Emissions Reduction Compared to Last Year tonnes 31000–41000

Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.

Standard Indicator Unit 2021 2022 2023-2025
Target Hazardous Waste Intensity Reduction Percentage Compared to Last Year % 0.5 0.5 0.5

Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2019 2020 2021
Biomass Energy tonne 6466 14.4
Coal Consumption tonne 72714.2 4336.5 86291
Diesel Fuel Consumption litre 362836.3 356192.6 328065.6
Energy Consumption Intensity (By Revenue) MWh/RMB10000 of output value 1
Gasoline Consumption litre 365628.3 278223.1 284665.6
LPG Consumption tonne 7.9
Natural Gas Consumption 10000 cubic meters 1111.5 917.9 598.6
Purchased Electricity kWh 374098694.8 400450102.9 398439861.9
Purchased Electricity Intensity (By Revenue) kWh/RMB10000 398.6 345.6 311.1
Purchased Steam tonne 284016.2 666196.9 376140.5
Renewable Energy Consumption tonne 6484.5 20.2 14.4
Solar Energy kWh 692280
Total Direct Energy Consumption MWh 572945.5
Total Energy Consumption MWh 1260532.9
Total Indirect Energy Consumption MWh 687587.4

Water consumption in total and intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2019 2020 2021
Discharge of Industrial Wastewater tonne 4368313.4 4285515 4222683.5
Recycled Water Usage tonne 2400
Water Consumption tonne 6385615.3 6264353.1 6096512.8
Water Consumption Intensity (By Revenue) tonne/RMB10000 6.8 5.4 4.8

Description of energy use efficiency target(s) set and steps taken to achieve them.

Standard Indicator Unit 2021
Electricity Usage Reduction Compared to Last Year kWh 6000000
Electricity Usage Reduction Percentage Compared to Last Year % 30
Energy Consumption Reduction Compared to Last Year kWh 494700
Energy Consumption Reduction Percentage Compared to Last Year % 20
Investment in Energy-saving and Emission-reduction Technology Transformation RMB 2180000
Steam Usage Reduction Compared to Last Year tonnes 180

Description of whether there is any issue in sourcing water that is fit for purpose, water efficiency target(s) set and steps taken to achieve them.

Standard Indicator Unit 2021
Wastewater Reduction Compared to Last Year 60000
Water Consumption Reduction Compared to Last Year tonnes 36180

Total packaging material used for finished products (in tonnes) and, if applicable, with reference to per unit produced.

Standard Indicator Unit 2019 2020 2021
Packaging Material Consumption (Paper) tonne 3095.7 3628.1 3791.5
Packaging Material Intensity (By Revenue) kg/RMB10000 3.3 3.1 7.9
Packaging Materials Consumed tonne 3095.7 3628.1 10162.3

Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.

Standard Indicator Unit 2021
Total Investment in Ecological Restoration million RMB 79.75

Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.

Standard Indicator Unit 2017 2018 2019 2020 2021
Number of Bachelor's Degree Employees employees 2452
Number of Below Junior College Employees employees 3246
Number of Doctoral Degree Employees employees 47
Number of Employees Aged 30-50 person 4838 5064 5389
Number of Employees Aged Above 50 person 401 413 458
Number of Employees Aged Below 30 person 3780 3303 3191
Number of Employees in Hong Kong person 1 4 2
Number of Employees in Mainland China person 9012 8353 8569
Number of Employees in Overseas person 6 10 9
Number of Female Employees person 3061 3494 4223 3975 4088
Number of Male Employees person 4796 4392 4492
Number of Master's Degree Employees employees 442
Number of Total Employees person 6950 9019 8367 8580
Percentage of Female Employees % 44 45.5 46.8 47.5 47.7

Employee turnover rate by gender, age group and geographical region.

Standard Indicator Unit 2019 2020 2021
Turnover Rate of Employees Aged 30-50 % 12.6 18.44
Turnover Rate of Employees Aged Above 50 % 4.12 21.78
Turnover Rate of Employees Aged Below 30 % 19.22 21.66
Turnover Rate of Employees in Hong Kong % 25 40
Turnover Rate of Employees in Mainland China % 14.79 19.72
Turnover Rate of Employees in Overseas % 20 37.5
Turnover Rate of Female Employees % 15.02 19.08
Turnover Rate of Male Employees % 14.59 20.73
Turnover Rate of Total Employees % 16.81 14.8 19.95

Lost days due to work injury.

Standard Indicator Unit 2019 2020 2021
Lost Days Due to Work-related Injuries day 547 155 180

Description of occupational health and safety measures adopted, and how they are implemented and monitored.

Standard Indicator Unit 2021
Investment in Work Safety RMB 22860000
Number of Production Safety Emergency Drills drills 6

The percentage of employees trained by gender and employee category (e.g. senior management, middle management).

Standard Indicator Unit 2020 2021
Percentage of Employees Trained % 99.56 100
Percentage of Trained Female Employees % 47.88 47.65
Percentage of Trained General Employees % 90.67 86.99
Percentage of Trained Middle Management % 7.03 9.91
Percentage of Trained Senior Management % 0.35 0.98

The average training hours completed per employee by gender and employee category.

Standard Indicator Unit 2019 2020 2021
Average Training Hours (Director and Above) hour 23.9 52.6
Average Training Hours (Female) hour 59.4 42.2 76.2
Average Training Hours (General Employees) hour 45.5 79.7
Average Training Hours (Male) hour 70 42.4 76.2
Average Training Hours (Middle Management) hour 23.4 56.2
Average Training Hours per Employee hour 65 42.3 76.2

Number of suppliers by geographical region.

Standard Indicator Unit 2021
Number of Suppliers in Central China number 148
Number of Suppliers in East China number 837
Number of Suppliers in North China number 196
Number of Suppliers in Northeast China number 30
Number of Suppliers in Northwest China number 99
Number of Suppliers in Overseas number 9
Number of Suppliers in South China number 689
Number of Suppliers in Southwest China number 47
Number of Total Suppliers number 2055

Number of products and service related complaints received and how they are dealt with.

Standard Indicator Unit 2019 2020 2021
Complaint Growth Rate percent 13.22 3.65
Number of Products and Service Related Complaints time 121 137 142
Total Number of Customer Complaints time 121 137 142

Description of anti-corruption training provided to directors and staff.

Standard Indicator Unit 2021
Average Anti-corruption Training Hours for Directors and Management hour/person 1.4375
Average Anti-corruption Training Hours for General Employees hour/person 4.123
Board Anti-corruption Training Duration hour 11.5
Number of Directors and Management Attendance for Anti-corruption Training person 8
Number of General Employees Attendance for Anti-corruption Training person 8580
Number of People Participated in Ethical Standards and Anti-corruption Training person 8588
Total Anti-corruption Training Hours for Directors and Management hour 11.5
Total Hours of Anti-corruption Training hour 35387.4
Total Hours of Anti-corruption Training for Employees hour 35375.9

Resources contributed (e.g. money or time) to the focus area.

Standard Indicator Unit 2021
Donations to Disaster Relief Contributions to Public Welfare million RMB 5
Investment in Education Donation million RMB 5.25
Total Cash Donations million RMB 13.5
Total In-kind Donations million RMB 5.95
Total Public Welfare Donations million RMB 19.45
Total Social Investment million RMB 19.45